Research Use Only · Dosing data compiled from published literature · Not for human or veterinary use

Cerebrolysin Dosage & Reconstitution

Porcine brain-derived peptide preparation. Work out exactly what to draw for your own mix, see the doses used in research, and follow a week-by-week plan. Evidence tier: clinical.

1Set Up Your Mix

20 mg/mL · 20000 mcg/mL

Your Answer — Cerebrolysin

60 mg in 3 mL
100Draw To This Line
1That's This Many mL
3Doses In The Vial
0102030405060708090100 U-100 syringe · 1 mL · 100 units draw to 100
60 mg ÷ 3 mL = 20 mg/mL  →  20 mg ÷ 20 mg/mL = 1 mL  →  × 100 = 100 units
Looks good. Draw to 100 units on a 1 mL syringe. That is an easy amount to measure, and this vial gives you 3 doses.
When to dose
Time of dayMorning and evening once the dose is split.
FoodWith or without food.

The protocol on this page is one injection in week 1 and two a day from week 2, so the timing follows the schedule rather than a fixed hour.

2Week-By-Week Plan — Cerebrolysin

Standard gradual approach
WhenDoseHow OftenHow Many mLDraw ToNumber Of DosesPeptide Used
Week 1 · 20 mg a day
one injection of 20 mg
20 mg daily 1 mL 100 u 7 140 mg
Week 2 · 24 mg a day
two injections of 12 mg — morning and evening
12 mg 2× daily 0.6 mL 60 u × 2 14 168 mg
Week 3 · 28 mg a day
two injections of 14 mg — morning and evening
14 mg 2× daily 0.7 mL 70 u × 2 14 196 mg
Week 4 onward · 32 mg a day most stop here
two injections of 16 mg — morning and evening
16 mg 2× daily 0.8 mL 80 u × 2 14 224 mg
Time to get there
4 weeks to the maintenance dose
Peptide used reaching that
504 mg
Vials you'll need
9 × 60 mg
Ongoing, once you settle
224 mg / 4 wk · 3.73 vials
Where this plan came from
A published protocol
Where this came from: OptimalDosages protocol. Written for a 60 mg vial in 3 mL, which gives 20 mg/mL. The daily total goes up every week. Week 1 is one injection of 20 mg; from week 2 the day is split into a morning and an evening injection, so the amount in the Dose column is what goes in each syringe, not the whole day. Change the water figure and every number recalculates.

3Common Doses — Cerebrolysin

worked out for your mix
LevelDoseHow OftenHow Many mLDraw ToDoses In Vial
Week 1 · 20 mg a day 20 mg once daily 1 mL 100 u 3 doses
Week 2 · 24 mg a day 12 mg 2× daily (AM + PM) 0.6 mL 60 u × 2 5 doses
Week 3 · 28 mg a day 14 mg 2× daily (AM + PM) 0.7 mL 70 u × 2 4 doses
Week 4 onward · 32 mg a day 16 mg 2× daily (AM + PM) 0.8 mL 80 u × 2 3 doses
Please read this. These numbers come from published research. They are here as reference, not as instructions. A lot of them come from lab studies rather than studies in people, and some of these peptides have never been given to a person at all.

About Cerebrolysin

Cognitive & Neuro
Also known as
Porcine brain-derived peptide preparation
Class
Cognitive & Neuro
Route
Subcutaneous
Half-life
Varies by fraction
Evidence tier
Clinical

Not a single peptide but a standardised mixture of low-molecular-weight peptides and amino acids of porcine origin. Approved in a number of countries for stroke and dementia; Cochrane reviews of the evidence have been notably unenthusiastic.

Buy Cerebrolysin

Common Questions — Cerebrolysin

How much bacteriostatic water do I add to a 60 mg vial of Cerebrolysin?

Adding 3 mL of bacteriostatic water to a 60 mg vial gives 20 mg/mL. That is the mix every number on this page is worked out from — change the water figure in the calculator and all the draw amounts update.

How many units on the syringe is a 20 mg dose of Cerebrolysin?

At 20 mg/mL, a 20 mg dose is 100 units on a 1 mL U-100 insulin syringe. One vial at that mix gives about 3 doses.

How strong is the evidence behind these Cerebrolysin doses?

Cerebrolysin is graded clinical. Human trial or approved-label dosing has been published for this compound. We grade every compound on this site so you can weigh the numbers accordingly — the full method is on our editorial policy page.

Where These Numbers Come From

Clinical — Human trial or approved-label dosing published
Cerebrolysin for acute ischaemic stroke — Cochrane systematic review Ziganshina LE, et al. Cochrane Database of Systematic Reviews, 2020
The critical appraisal; concludes evidence of benefit is not established.
Find on PubMed ↗
Cerebrolysin in vascular dementia — randomised trial Guekht A, et al. Journal of the Neurological Sciences, 2011
A positive-result trial; useful to read against the Cochrane appraisal.
Find on PubMed ↗

Newest Studies —

Not reviewed by us. This list is pulled straight from Europe PMC as papers are published. Nobody has checked whether these are any good, or whether they change anything above. The dose numbers on this page only ever change after a person reviews the evidence.

Other cognitive & neuro peptides

Compounds in the same class, or browse the full catalogue.

ARA-290

An 11-amino-acid erythropoietin derivative that engages the innate repair receptor without the erythropoietic or thrombotic effect…

DSIP

A nonapeptide originally isolated from cerebral venous blood during induced sleep. Despite the name, controlled human sleep-archit…

All 72 peptides

Every compound compared in one table: dose range, how often, half-life and evidence tier.

Need this on one page to print, screenshot or send?

Make a dose card →